Pharmacokinetic Interactions Between the Hepatitis C Virus Protease Inhibitor Boceprevir and Ritonavir-Boosted HIV-1 Protease Inhibitors Atazanavir, Darunavir, and Lopinavir-Reference-Cited by-同舟云学术

Pharmacokinetic Interactions Between the Hepatitis C Virus Protease Inhibitor Boceprevir and Ritonavir-Boosted HIV-1 Protease Inhibitors Atazanavir, Darunavir, and Lopinavir

Published:2012-11-15 Issue:5 Volume:56 Page:718-726
ISSN:1537-6591
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Hulskotte Ellen G. J.,Feng Hwa-Ping,Xuan Fengjuan,van Zutven Marga G. J. A.,Treitel Michelle A.,Hughes Eric A.,O'Mara Edward,Youngberg Stephen P.,Wagner John A.,Butterton Joan R.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/56/5/718/17851387/cis968.pdf

Reference28 articles.

1. Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection;Monga;Clin Infect Dis,2001

2. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis;Graham;Clin Infect Dis,2001

3. Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial;Carrat;JAMA,2004

4. Peginterferon alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons;Chung;N Engl J Med,2004

5. SCH 503034, a mechanism-based inhibitor of hepatitis C virus NS3 protease, suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon cells;Malcolm;Antimicrob Agents Chemother,2006

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Factors and Pathways of Hepatotoxicity Associated with HIV/SARS-CoV-2 Protease Inhibitors;International Journal of Molecular Sciences;2023-04-27

2. Real‐world treatment outcomes of sofosbuvir‐based regimens for treatment of chronic hepatitis C with and without human immunodeficiency virus co‐infection;JGH Open;2023-01-26

3. Designing Out PXR Activity on Drug Discovery Projects: A Review of Structure-Based Methods, Empirical and Computational Approaches;Journal of Medicinal Chemistry;2021-05-18

4. Real-World Clinical Efficacy and Tolerability of Direct-Acting Antivirals in Hepatitis C Monoinfection Compared to Hepatitis C/Human Immunodeficiency Virus Coinfection in a Community Care Setting;Gut and Liver;2018-11-15

5. Boceprevir and Antiretroviral Pharmacokinetic Interactions in HIV/HCV Co-infected Persons: AIDS Clinical Trials Group Study A5309s;Drugs in R&D;2017-09-05